Key result
Concomitant moderate or greater left-sided valve disease during T-TEER is linked to ~54% higher mortality.
Why the study?
The prognostic impact of coexisting left-sided valvular heart disease on clinical outcomes after tricuspid valve edge-to-edge repair remains unclear under real-world conditions.
Does concomitant left-sided valvular heart disease worsen survival and heart failure hospitalizations in patients undergoing tricuspid valve transcatheter edge-to-edge repair?
Observational (n=1,647)
Yes
Does concomitant left-sided valvular heart disease worsen survival and heart failure hospitalizations in patients undergoing tricuspid valve transcatheter edge-to-edge repair?
Answers are grounded in this paper and cite their sources.
Concomitant left-sided valvular heart disease is common in patients undergoing T-TEER and independently predicts worse survival and higher heart failure hospitalization rates, though T-TEER still provides symptomatic benefit and TR reduction.
BACKGROUND AND AIMS: The impact of coexisting left-sided valvular heart disease (VHD) on clinical outcomes following tricuspid valve edge-to-edge repair (T-TEER) for tricuspid regurgitation (TR) remains unclear, particularly under real-world conditions. OBJECTIVES: To evaluate the prevalence and prognostic impact of concomitant left-sided VHD in patients undergoing T-TEER. METHODS: This study included all patients undergoing T-TEER from EuroTR (European Registry of Transcatheter Repair for Tricuspid Regurgitation; NCT06307262) with complete echocardiographic data on left sided valve disease. Study endpoints included survival and heart failure hospitalizations (HFH) at 2 years, NYHA functional class and TR reduction. RESULTS: Among a total of 1,647 eligible patients, 95.8%, 35.6% and 3.8% had ≥ mild, moderate and severe concomitant VHD, respectively. Moderate or higher VHD was associated with a significantly reduced 2-year survival (p<0.001) and reduced 2-year HFH-free survival (p=0.005). Multivariate regression analysis confirmed ≥ moderate VHD to be an independent predictor of mortality (Hazard ratio 1.54, 95% CI 1.21-1.96, p<0.001). Despite worse TR and NYHA functional class at baseline in patients with ≥ moderate VHD, T-TEER was associated with a significant TR reduction (p<0.001) and symptomatic improvement (p<0.001). CONCLUSIONS: Concomitant left-sided VHD is common among patients undergoing T-TEER and is independently associated with worse survival and higher rates of HFH. Nevertheless, T-TEER provides meaningful symptomatic benefit and durable TR reduction in patients with and without VHD burden.
No takes yet. Share an insight, caveat, or question.
Gmeiner et al. (2026) conducted an observational in Tricuspid regurgitation (n=1,647). Concomitant left-sided valvular heart disease (≥ moderate) vs. No or mild concomitant left-sided valvular heart disease was evaluated on Mortality (HR 1.54, 95% CI 1.21-1.96, p=<0.001). Concomitant moderate or greater left-sided valvular heart disease in patients undergoing T-TEER was an independent predictor of mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: